Evidence map›Paper›PMID 30777946›Full record

ReviewIndian journal of ophthalmology2019

Enigma of serpiginous choroiditis.

Parthopratim Dutta Majumder, Jyotirmay Biswas, Amod Gupta

Open access · diamondAbstract readReview
In one paragraph

Review in Indian journal of ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Sarcoid Uveitis with Choroidal Involvement.Clinical ophthalmology (Auckland, N.Z.) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. [Serpiginous-Like Choroiditis: literature Review]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2022
    Review
  13. Article
  14. Review
  15. Chlorambucil combination therapy in refractory serpiginous choroiditis: A cure?American journal of ophthalmology case reports · 2021
    Article
  16. Article
  17. Bilateral Ampiginous Choroiditis following Presumed SARS-CoV-2 Infection.Case reports in ophthalmological medicine · 2021
    Article
  18. [Treatment of ocular tuberculosis-an update].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
    Review
  19. Article
  20. Commentary: Serpiginous choroiditis-so near yet so far.Indian journal of ophthalmology · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Parthopratim Dutta MajumderDepartment of Uvea and Intraocular Inflammation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Jyotirmay BiswasDepartment of Uvea and Department of Larsen and Toubro Ocular Pathology, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Amod GuptaAdvanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sankara Nethralaya · INPost Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serpiginous choroiditis (SC) is an asymmetrically bilateral inflammation of the choroid that leads to loss of choriocapillaris atrophy or loss of overlying retinal pigment epithelium. Over the last few decades, SC has passed through a long evolution of nomenclature, etiologies and morphological variations. Initially diagnosed in patients with tuberculosis and syphilis, SC was predominantly considered as autoimmune process. With the advancement of molecular diagnosis, a new aspect of infectious subtypes of SC has emerged out. The terminologies such as serpiginous-like choroiditis (SLC) and multifocal serpiginoid choroiditis are now used to denote the subtypes of SC which are associated with infectious etiologies especially tuberculosis. In a country endemic for tuberculosis such as India, it is very important to differentiate between classic SC and SLC before initiating aggressive immunomodulatory therapy. Also, management of paradoxical worsening of the clinical condition with antitubercular treatment is another challenge in SLC and ophthalmologists should be aware of such situations. With advent of newer imaging modalities, monitoring the patient with choroiditis and identification of complications such as choroidal neovascular membrane have become much easier. This article aims to review the existing literature on SC with a special emphasis on management of SC and SLC.

Indexed as

ChoroidChoroiditisDiagnosis, DifferentialFluorescein AngiographyFundus OculiHumansMultifocal ChoroiditisRetinal Pigment EpitheliumTomography, Optical CoherenceImmunosuppressivemultifocal choroiditisoptical coherence tomography angiographyserpiginous choroiditisserpiginous-like choroiditistuberculosis

Identifiers

PMID30777946
PMCPMC6407399
OpenAlexW2917455798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.